+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Tricyclic imidazoline derivatives as potent and selective adenosine A1 receptor antagonists



Tricyclic imidazoline derivatives as potent and selective adenosine A1 receptor antagonists



Journal of Medicinal Chemistry 49(24): 7132-7139



Novel tricyclic imidazoline antagonists of the adenosine A(1) receptor are described. For key compounds, the selectivity level over other adenosine receptor subtypes is examined along with their in vivo effects in a rat diuresis model. Compound 14, the (R)-isomer of 7,8-dihydro-8-ethyl-2-(4-bicyclo[2.2.2]octan-1-ol)-4-propyl-1H-imidazo[2,1-i]purin-5(4H)-one, is a particularly potent adenosine A1 receptor antagonist with good selectivity over the other three adenosine receptor subtypes: A(1) (human) K-i=22 nM; A(2A) (human) K-i = 4400 nM; A(2B) (human) Ki) 580 nM; A(3) (human) K-i >= 10 000 nM. Imidazoline 14 is a competitive adenosine A1 receptor antagonist with a pA(2) value of 8.88 and is highly soluble in water (> 100 mg/mL). In addition, it has an oral bioavailability of 84% and an oral half-life of 3.8 h in rats. When orally administered in a rat diuresis model, compound 14 promoted sodium excretion (ED50=0.01 mg/ kg). This level of efficacy is comparable to that of BG9928, a selective adenosine A(1) receptor antagonist that is currently in clinical trials as a treatment for congestive heart failure. Additional modifications to 14 also showed that the bridgehead hydroxyl group could be replaced with a propionic acid (compound 36) without a significant loss in binding affinity or in vivo activity.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 012897000

Download citation: RISBibTeXText

PMID: 17125265

DOI: 10.1021/jm060539t


Related references

Imidazo[2,1- i ]purin-5-ones and Related Tricyclic Water-Soluble Purine Derivatives: Potent A 2A - and A 3 -Adenosine Receptor Antagonists. Journal of Medicinal Chemistry 45(16): 3440-3450, 2002

Imidazo[2,1-i]purin-5-ones and related tricyclic water-soluble purine derivatives: potent A(2A)- and A(3)-adenosine receptor antagonists. Journal of Medicinal Chemistry 45(16): 3440-3450, 2002

Structure-activity relationships of truncated adenosine derivatives as highly potent and selective human A3 adenosine receptor antagonists. Bioorganic and Medicinal Chemistry 17(10): 3733-3738, 2009

Pyrimidine derivatives as potent and selective A3 adenosine receptor antagonists. Journal of Medicinal Chemistry 54(2): 457-471, 2011

6-phenyl-1,4-dihydropyridine derivatives as potent and selective A3 adenosine receptor antagonists. Journal of Medicinal Chemistry 39(23): 4667-4675, 1996

1,8-disubstituted xanthine derivatives Potent A2B-selective adenosine receptor antagonists. Drug Development Research 56(4): 558, 2002

Derivatives of 4-amino-6-hydroxy-2-mercaptopyrimidine as novel, potent, and selective A3 adenosine receptor antagonists. Journal of Medicinal Chemistry 51(6): 1764-1770, 2008

"Reversine" and its 2-substituted adenine derivatives as potent and selective A3 adenosine receptor antagonists. Journal of Medicinal Chemistry 48(15): 4910-4918, 2005

Novel diamino derivatives of [1,2,4]triazolo[1,5-a][1,3,5]triazine as potent and selective adenosine A2a receptor antagonists. Journal of Medicinal Chemistry 48(6): 2009-2018, 2005

1,8-Disubstituted Xanthine Derivatives: Synthesis of Potent A 2B -Selective Adenosine Receptor Antagonists. Journal of Medicinal Chemistry 45(7): 1500-1510, 2002

Piperazine derivatives of triazolo triazine as potent and selective adenosine A2a receptor antagonists. Journal of Medicinal Chemistry 47(17): 4291-4299, 2004

Discovery of N-(5,6-diarylpyridin-2-yl)amide derivatives as potent and selective A(2B) adenosine receptor antagonists. Bioorganic and Medicinal Chemistry Letters 20(5): 1697-1700, 2010

Highly potent and selective human adenosine A3 receptor antagonists Triazoloquinazoline derivatives. Abstracts of Papers American Chemical Society 213(1-3): MEDI 42, 1997

1,8-disubstituted xanthine derivatives: synthesis of potent A2B-selective adenosine receptor antagonists. Journal of Medicinal Chemistry 45(7): 1500-1510, 2002

New 2-arylpyrazolo[4,3-c]quinoline derivatives as potent and selective human A3 adenosine receptor antagonists. Journal of Medicinal Chemistry 48(15): 5001-5008, 2005